Global Non-Small Cell Lung Cancer Therapeutics Market: Segmental Highlights and Table of Content (2015–2023)
The global market for non-small cell lung cancer therapeutics is expected to be worth US$15.1 bn by 2023. On the basis of geography, Asia Pacific will emerge as the most lucrative regional market on account of growing awareness about cancer and increasing number of government projects supporting lung cancer treatment. On the basis of drugs, the angiogenesis inhibitor segment is estimated to lead on account of the efficacious nature of this drug and rise in the adoption of targeted therapy...
View full press release